| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 8.944 | 41.242 | 69.687 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 8.945 | 41.244 | 69.724 |
| Total Expenses - EUR | - | - | - | - | - | - | 0 | 4.923 | 16.263 | 47.188 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 0 | 4.022 | 24.981 | 22.536 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 0 | 3.898 | 24.630 | 20.445 |
| Employees | - | - | - | - | - | - | 0 | 1 | 2 | 2 |
Check the financial reports for the company - Diabetescontrol&Nutrimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 885 | 39.711 |
| Current Assets | - | - | - | - | - | - | 40 | 9.763 | 29.838 | 53.851 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 4.056 | 12.560 | 23.981 |
| Cash | - | - | - | - | - | - | 40 | 5.707 | 17.279 | 24.844 |
| Shareholders Funds | - | - | - | - | - | - | 40 | 3.939 | 28.557 | 20.496 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 0 | 5.824 | 2.167 | 73.066 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diabetescontrol&Nutrimed S.r.l.